The impact of combining human and online supportive resources for prostate cancer patientsDecember 15, 2017Genitourinary CancerPatient & Survivor Care
Metastatic eccrine carcinoma with stomach and pericardial involvementDecember 15, 2017MelanomaPatient & Survivor Care
Pembrolizumab for dMMR/MSI-H tumors marks first tumor agnostic FDA approvalDecember 15, 2017GastroenterologyGynecologic Cancer
Brigatinib approval yields additional treatment options for crizotinib-resistant, ALK-positive NSCLC patientsDecember 15, 2017Lung Cancer
Hallmark tumor metabolism becomes a validated therapeutic targetDecember 10, 2017Breast CancerGastroenterologyGenitourinary CancerLeukemia, Myelodysplasia, Transplantation
The effect of centralizing breast cancer care in an urban public hospitalDecember 1, 2017Breast CancerPatient & Survivor Care
Palliative and supportive interventions to improve patient-reported outcomes in rural residents with cancerDecember 1, 2017Patient & Survivor Care
Adverse events from systemic treatment of cancer and patient-reported quality of lifeDecember 1, 2017Patient & Survivor Care
Familial essential thrombocythemia associated with JAK2 V617F mutation in siblingsDecember 1, 2017Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Management of tonsillar carcinoma with advanced radiation therapy and chemotherapy techniquesDecember 1, 2017Head & Neck/Thyroid CancersPatient & Survivor Care
PD-L1-targeting drug atezolizumab nabs approval for non-small cell lung cancerDecember 1, 2017Lung Cancer
It's all about the care: new takes on access, quality, consolidation, and outcomesDecember 1, 2017Patient & Survivor Care
